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ABSTRACT
Shiga toxin–producing Escherichia coli (STEC) comprise a large, highly diverse group of strains. Since the emergence of
STEC serotype O157:H7 as an important foodborne pathogen, serotype data have been used for identifying STEC strains, and
this use continued as other serotypes were implicated in human infections. An estimated 470 STEC serotypes have been
identified, which can produce one or more of the 12 known Shiga toxin (Stx) subtypes. The number of STEC serotypes that cause
human illness varies but is probably higher than 100. However, many STEC virulence genes are mobile and can be lost or
transferred to other bacteria; therefore, STEC strains that have the same serotype may not carry the same virulence genes or pose
the same risk. Although serotype information is useful in outbreak investigations and surveillance studies, it is not a reliable
means of assessing the human health risk posed by a particular STEC serotype. To contribute to the development of a set of
criteria that would more reliably support hazard identification, this review considered each of the factors contributing to a
negative human health outcome: mild diarrhea, bloody diarrhea, and hemolytic uremic syndrome (HUS). STEC pathogenesis
involves entry into the human gut (often via ingestion), attachment to the intestinal epithelial cells, and elaboration of Stx.
Production of Stx, which disrupts normal cellular functions and causes cell damage, alone without adherence of bacterial cells to
gut epithelial cells is insufficient to cause severe illness. The principal adherence factor in STEC is the intimin protein coded by
the eae gene. The aggregative adherence fimbriae adhesins regulated by the aggR gene of enteroaggregative E. coli strains are
also effective adherence factors. The stx2a gene is most often present in locus of enterocyte effacement (eae)–positive STEC
strains and has consistently been associated with HUS. The stx2a gene has also been found in eae-negative, aggR-positive STEC
that have caused HUS. HUS cases where other stx gene subtypes were identified indicate that other factors such as host
susceptibility and the genetic cocktail of virulence genes in individual isolates may affect their association with severe diseases.
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Shiga toxin–producing Escherichia coli (STEC) is a
large, complex group of E. coli strains that vary greatly in
phenotypic, serologic, and genotypic characteristics. STEC
pathogenesis is highly complex, requiring multiple virulence
factors to cause severe diseases. Some of these virulence
factors have many subtypes or alleles, not all of which seem
to affect humans. Many of these STEC proven and putative
virulence factors reside on mobile genetic elements and can
be lost or transferred. As a result, strains of the same
serotype may have different virulence genes and pose
different health risks. The Food and Agriculture Organiza-
tion of the United Nations (FAO) and the World Health
Organization (WHO) were asked to provide advice to the
Codex Committee on Food Hygiene on a number of aspects
related management of STEC in the food chain, one of
which was the identification of the hazard. A Joint FAO/
WHO Expert Meeting on Microbiological Risk Assessment
(JEMRA) Group was convened to address this issue. The
JEMRA Group decided that a set of criteria and/or a
decision tree (http://www.fao.org/3/ca0032en/CA0032EN.
pdf) based on current knowledge of factors known to be
required in STEC pathogenesis and of phenotypes histori-
cally linked with disease should be developed to provide a
harmonized risk-based approach for characterization of
STEC isolated from a food or along the food chain. A
database of strains and serotypes could be developed to
facilitate application of the decision tree. For example, the
database could include information on strains that have
certain patterns when assessed against the criteria used in the
decision tree and historically linked in different regions with
various levels of health risk from severe to minimal or when
no known risk has been reported. This characterization,
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together with other factors such as knowledge of the intrinsic
nature of the food, further handling that may affect survival,
food preparation practices before consumption, and whether
the food is to be provided to known high-risk consumer
groups, could be used for determining the potential human
health risk posed by an STEC strain found in the food chain.
Pathogenicity of STEC is complex, but in general
infection entails three features: ingestion of a contaminated
food or other vehicle, colonization of intestinal epithelial
cells by STEC, and production of Shiga toxins (Stx), which
disrupt normal cellular functions and cause cell damage. The
evidence suggests that production of Stx alone without
adherence of bacterial cells to gut epithelial cells is
insufficient to cause severe illness. STEC infection can be
asymptomatic. Most people who come to medical attention
have diarrhea, which is often bloody and can be hemor-
rhagic (hence the term enterohemorrhagic E. coli). Hemo-
lytic uremic syndrome (HUS) is the most important
complication (58), and some patients with HUS develop
chronic renal failure. People with STEC infection with or
without HUS can die. This risk-based discussion focuses on
mild diarrhea, bloody diarrhea (BD), and HUS.
ADHERENCE FACTORS
The majority of STEC known to cause BD or HUS have
virulence factors that enable attachment to intestinal
epithelial cells, so adherence factors are generally consid-
ered essential for severe illness and perhaps even for non-
BD. The main adherence factor in STEC is the intimin
protein coded by the eae gene that resides on the locus of
enterocyte effacement (LEE) pathogenicity island. Intimin is
also a virulence factor of enteropathogenic E. coli (EPEC)
and is crucial in the attaching-effacing lesion that has been
associated with EPEC and LEE-positive STEC strains (78).
The eae gene is highly polymorphic, with over 34 genetic
variants (alleles) (72, 89), which are designated by Greek
letters. For example, E. coli O157:H7 carries c (gamma) eae,
serotype O26:H11 often has b (beta) eae, and serotype
O121:H19 has e (epsilon) eae. The presence of both eae and
the Stx gene stx2 is a reliable predictor that the STEC strain
may cause BD or HUS (40).
LEE-negative (i.e., eae-negative) STEC has been
implicated as a cause of severe disease (112). For example,
an STEC O113:H21 strain was first isolated from a child
with HUS in 1983 (83), and this serotype later caused a
cluster of HUS cases in Australia (122). STEC O91:H21
strains that are also LEE negative have been implicated in
HUS cases in Germany (99, 100). LEE-negative STEC
strains probably have other means or mechanisms for
adherence (36). The O113:H21 strains have the STEC
agglutinating adhesin (121). The sab gene that codes for an
outer membrane autotransporter protein that enhances
biofilm formation (70) is also thought to be an adherence
factor. Evaluations of other STEC strains have revealed the
presence of paa, efa1, ompA, lpfA, and other genes that code
for adhesins (78). The plasmid-borne toxB gene also codes
for an adhesin and is found in O157:H7 and many LEE-
positive STEC strains, including strains of the O26, O121,
and O145 serogroups, and in EPEC strains (154). The toxB-
encoded adhesin is thought to contribute to the adherence
properties of the O157:H7 serotype. However, like other
adhesins, the role of the toxB adhesin in STEC virulence has
not been fully determined, so this adhesin is often regarded
as a putative virulence factor, and its prevalence differs
among STEC strains (42). In a recent study, an 86-kb mosaic
pathogenicity island (PAI) named the locus of adhesion and
autoaggregation (LAA) was reported, which is composed of
four modules of 80 genes, including those that code for
novel and known virulence factors associated with adher-
ence and autoaggregation (104). Phylogenomic analysis
revealed that LAA appears to be exclusively present in a
subset of emerging LEE-negative STEC strains, including
strains from hemorrhagic colitis and HUS cases. LAA
acquisition may be a recent evolutionary event, which may
have contributed to the emergence of these STEC strains
(104).
By far the most compelling evidence that adherence is
critical to severe disease outcome is the enteroaggregative E.
coli (EAEC) O104:H4 strain, which caused the large HUS
outbreak in Germany in 2011 (48). EAEC strains do not
have eae but have the aggregative adherence fimbriae (AAF)
adhesins regulated by the aggR gene. The ability of
O104:H4 strains to aggregate on epithelial cells coupled
with Stx2 production resulted in a remarkably high HUS rate
of 22% (20). This outbreak indicated that an adherence
factor other than eae, in combination with stx2a, can produce
severe disease (8). Some public health agencies are now
testing STEC for both eae and aggR to detect EAEC strains
that have acquired the ability to produce Stx. Because the
aggR genes reside on plasmids that can be lost after disease
is produced, chromosomal markers such as the aaiC gene
have also been used to identify EAEC strains (38).
Key Points on Adherence Factors
1. Adherence factors are critical factors for STEC pathoge-
nicity.
2. The principal adherence factor in STEC is the intimin
protein coded by the eae gene.
3. The AAF adhesins regulated by the aggR gene of EAEC
are also effective adherence factors.
4. Other putative STEC adherence factors include those
coded by genes saa, sab, paa, efa1, ompA, lpfA, toxB,
and the LAA PAI.
STX TYPES AND SUBTYPES
STEC are characterized by the production of Stx, of
which two main types have been described, Stx1 and Stx2,
with three Stx1 (Stx1a, Stx1c, and Stx1d) and seven Stx2
(Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g)
subtypes (137). A novel subtype of Stx1, Stx1e (GenBank
accession no. KF926684), which has limited reactivity with
anti-Stx1 antibodies, has been found in Enterobacter
cloacae (128). Provisional designations also have been
proposed (88) for two new Stx2 subtypes, encoded by genes
stx2h (GenBank AM904726) and stx2i (GenBank
FN252457), but the proposed sequence of stx2h was found
to be identical to the already published variant stx2e-O8-FHI-
1106-1092 (137). STEC strains can produce any of the Stx
or a combination of Stx subtypes, but not all subtypes have
8 FAO/WHO STEC EXPERT GROUP J. Food Prot., Vol. 82, No. 1
been implicated in severe illness (71, 96). For example,
among the Stx1 group, little is known about the clinical
significance of the Stx1d subtype. Stx1c is the most common
subtype in strains isolated from sheep, wild deer, and
wildlife meats (24, 71, 106); these strains often do not
produce intimin and tend to cause asymptomatic infection or
mild diarrhea (51). The Stx1a subtype is often produced by
LEE-positive STEC strains that have caused severe
infections, including serotypes O157:H7, O26:H11, and
O111:H8. Brooks et al. (25) found that 83% of O26, 50% of
O111, and 100% of O103 strains that caused BD in the
United States carried stx1 and eae, but of these, only one
O111 strain was implicated in HUS. Consistent with those
observations, O103:H2 is the second most common STEC
causing infection in Norway but is not associated with HUS
(110). These three O groups have been declared as
adulterants in raw nonintact beef and intact beef products
intended for nonintact use in the United States (156). Some
STEC serotypes with stx1a and eae are found in foods (45)
but have not been implicated in human infections,
suggesting that not all STEC that produce Stx1a and have
eae pose the same health risk. STEC with stx1c, either alone
or together with stx2b, is often isolated from wild ruminants.
Most of these strains are eae negative (71), so their presence
in humans has not received much attention. However, in
some studies 10 to 15% of clinical samples from patients
with diarrheal illnesses have been positive for stx1c and/or
stx2b (22, 26, 32, 47).
Stx2 is more important than Stx1 in the development of
HUS (35). Among the Stx2 group, the subtypes most often
associated with severe disease are Stx2a, Stx2c, and Stx2d
(50, 124). Some researchers have suggested that other
subtypes may also cause severe infections. Some Stx2
subtypes share high gene sequence similarities and have
probably been misidentified in some reports. The nomen-
clature for Stx subtypes is continually being refined.
Increased use of whole genome sequencing should help to
clarify the associations of Stx subtypes with severe diseases.
Whole genome sequencing results have also indicated that
different stx subtypes are associated with different virulence
profiles. In a study from The Netherlands, the genes ehxA
and ureC were significantly associated with HUS-associated
STEC strains but not with the presence of eae (49),
suggesting that these genes could be important pathogenicity
markers next to eae and stx2a.
The Stx2b subtype was proposed to designate a strain
subtype with a variant of the stx2c gene but that did not cause
HUS (124). Analysis of STEC in Europe revealed that stx2b
alone or together with stx1c is common in STEC from deer
droppings and wildlife populations (71, 106) but does not
appear to cause severe human illness (21, 27, 32, 47). The
Stx2e subtype is mostly found in isolates from pigs and pork
meat (9) and is commonly associated with pig edema disease
(7). STEC with stx2e have been isolated from fresh produce
(45) and rarely from humans; in one study the frequency of
isolation of STEC with stx2e was similar among people with
and without diarrhea (50). In another study, isolation of
Stx2e-producing STEC was not correlated with diarrheal
illness (7), suggesting that Stx2e-producing strains are
generally not pathogenic for humans. However, Fasel et
al. (41) reported the isolation of an STEC O51:H49 strain
with stx2e and eae from a 65-year-old patient with HUS in
Switzerland, and in another study, stx2e was found in STEC
O9abH and O101:H strains isolated from an HUS patient
(151).
The Stx2f subtype has a genetic sequence that is very
distinct from that of the other Stx2 subtypes, and the
designation Stx2f was first applied to STEC strains isolated
from pigeons (139), although this subtype was first reported
as Shiga-like toxin IIva from an STEC strain isolated from
an infant with diarrhea (56). Analyses of STEC isolates from
the wild, from bovine farm environments, and from humans
have seldom found Stx2f (50, 71, 103). Some studies
suggested that an STEC strain that produce Stx2f can cause
mild diarrhea or can be asymptomatic (54, 126), but it
appears to be rare (71, 124). However, in a recent study an
STEC O8:H19 strain that carried both stx2f and eae was
isolated from an HUS patient in The Netherlands (53), and
others have also reported isolating Stx2f-producing STEC
strains from HUS patients (63). Additional information is
needed to understand the association between Stx2f and
severe illness.
STEC with the Stx2g subtype was first isolated from
bacteriophages in water with fecal contamination (57). The
Stx2g subtype was also found in 8.4% of the STEC strains
isolated from farm environments (103) and in some STEC
strains isolated from foods (9). STEC strains with stx2g have
rarely been isolated from human samples (9). Such a strain
was isolated from German patients with diarrhea, fever, and
abdominal pain but has not been implicated in severe
diseases (125).
Several researchers have indicated that subtypes Stx2a
or Stx2d are significantly associated with the risk of BD,
HUS, or both (22, 26, 40, 94, 99, 124). These subtypes were
at least 25 times more potent than Stx2b and Stx2c in
cytotoxicity assays using primary human renal proximal
tubule epithelial cells and Vero cells (55). In mice, the
potencies of Stx2b and Stx2c are similar to those of Stx1,
whereas Stx2a and Stx2d were 40 to 400 times more potent
than Stx1 (55).
In STEC O157:H7, four major and two minor subtypes
of stx2-encoding bacteriophages have been studied to
determine the production of Stx2a (115). One of the two
bacteriophage subclades in clade 8, a hypervirulent lineage
of serotype O157:H7, confers the highest Stx2a production
in the host strain (115). Striking phage-related variability in
toxin production has been observed in clinical isolates of
O157 as well as in other O groups (O83, O111, and O145).
The genotype of the bacteriophage and host strain factors are
relevant to STEC pathogenesis (158) as was recently
demonstrated in a whole genome sequencing comparison
of Stx2f-producing STEC strains, some of which were
isolated from patients with HUS (63). In that study, only the
three strains isolated from HUS patients had the EPEC-
associated efa1 gene, which resides on the PAI OI122, the
STEC plasmid genes ehxA, espP, and katP, and intimin type
n (xi) or b. The stx2f STEC strains isolated from patients
with diarrhea but without HUS and the strains isolated from
pigeons lacked these genes (63). Although some of these
genes, such as ehxA that codes for enterohemolysin, are
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prevalent in STEC strains that have caused severe infections,
their role in STEC pathogenesis remains undetermined.
Nevertheless, this example suggests that the genotype of the
host strain can have an effect on disease outcomes.
The Stx2d subtype has been suggested as an indicator
for severe clinical outcomes such as BD or HUS (12). This
subtype used to be known as stx2d activatable because it was
activated by elastase in mucus to become 10- to 1,000-fold
more cytotoxic (102). In a French outbreak caused by a
hybrid STEC–extraintestinal pathogenic E. coli (ExPEC)
strain of serotype O80:H2, stx2d in combination with other
stx subtypes was found in 69% of the 52 strains isolated
from HUS patients. Among the isolates, 62% had stx2c/2d,
7% had stx2a/2d, and 31% had unique variants of stx2a (22%)
or stx2d (9%). All 52 strains had the intimin variant eae-n,
and 87% carried the ehxA gene (95). All 52 O80:H2 strains
examined also shared the four genes (sitA, cia, hlyF, and
ompT) that are characteristic of the ExPEC pS88 plasmid
and other ExPEC traits, 98% carried the iss and iroN genes,
96% had the cvaA gene, and 61% had the iucC and etsC
genes (142). In a study in Spain, 236 STEC strains isolated
from patients with HUS, diarrhea, or both were evaluated.
Of these, 193 were eae positive, 43 were eae negative, and 7
(3%) carried stx2d (135). Further analysis revealed that six of
the stx2d-bearing strains were eae-negative STEC of
serotypes O73:H18, O91:H21, O148:H8, O181:H49, and
ONT:H21 and one was an O157:H7 strain that was also
positive for stx2c and eae. In a study of 32 isolates of
O26:H11 sequence type 29 recovered from patients with
HUS between 2010 and 2013 in France, 7 isolates were
positive for stx2d, eae-b, and SP_26_E (using a CRISPR-
based assay) but lacked any of the usual plasmid genes
associated with O26 strains (33). Although these findings
indicate that Stx2d causes severe infections, not all STEC
strains with stx2d may causes severe disease. For example,
nine patients in Norway infected with an stx2d-positive
STEC strain did not develop HUS (22). In an outbreak of
gastroenteritis in Japan, both Escherichia albertii and STEC
O183:H18 that were stx2d positive were isolated, but none of
the 44 patients examined developed BD or HUS (21, 118).
In a large study of 626 STEC infections in Germany, none of
the 268 HUS patients were infected with an STEC strain that
was positive for stx2d (50). At least 18 genetic variants of the
stx2d subtype have been identified, and eight of the strains
tested were variable in being activatable by elastase (137),
which may account for the variability in clinical outcomes
associated with Stx2d strains.
Because of sequence similarities, genes stx2a, stx2c, and
stx2d can be quite difficult to discern and identify (137). The
stx2c-positive strains had been thought to cause severe
disease and HUS (37, 50, 124), but recent information has
doubts about this assumption. For example, the European
Food Safety Authority (EFSA) Panel on Biological Hazards
(37) stated that O111 strains isolated from HUS patients
(162) were stx2c positive. However, the alignment of the two
sequenced strains revealed 100% homology with the stx2
sequences found in O157:H7 strain EDL933, which is
known to have stx2a but not stx2c (137). Persson et al. (124)
examined 20 STEC strains isolated from HUS patients and
found only 1 strain that had stx2c alone. That strain has since
been sequenced (unpublished data) and identified as
belonging to clade 8 of O157:H7, which is known to have
stx2a but not stx2c (115). Friedrich et al. (50) did not find a
significant difference in the prevalence of stx2c between
STEC isolates from patients with HUS versus those from
patients with diarrhea (P¼ 0.49) nor between isolates from
patients with HUS versus those from asymptomatic patients
(P ¼ 0.74). Additional data obtained with discriminating
molecular subtyping methods may clarify whether stx2c is
strongly associated with severe disease.
Large genotypic differences in stx phage have also been
observed in LEE-negative STEC strains (146). The
virulence potential of STEC is quite likely determined by
a combination of factors, including bacteriophage clade, stx
subtype, and genotype of the bacterial host. Consistent with
those assumptions, identification of the specific stx subtype,
the bacteriophage mechanisms that control Stx production,
and selected virulence genes carried by a particular STEC
strain would be useful for assessing health risks, especially
considering that not all Stx subtypes appear to affect humans
and that some subtypes are more often associated with
severe illnesses than are others.
Key Points on Stx
1. Twelve subtypes of Stx have thus far been identified:
Stx1a, Stx1c, Stx1d, Stx1e, and Stx2 subtypes Stx2a to
Stx2g, and Stx2i, encoded by genes stx1a, stx1c, stx1d,
stx1e, stx2a to stx2g, and stx2i, respectively.
2. The gene stx2a is often found in LEE (eae)–positive
STEC and has consistently been associated with HUS.
3. The gene stx2a has also been found in eae-negative,
aggR-positive STEC that have caused HUS.
4. The gene stx2d in LEE-negative strains has to a lesser
degree been reported from cases of HUS, but not all
STEC strains with stx2d may cause severe disease.
5. HUS cases associated with other Stx subtypes have been
identified, indicating that other factors such as host
susceptibility, the genetic cocktail of virulence genes in
individual isolates, and other (bacteriophage related)
factors may affect the association of other Stx subtypes
with severe disease.
SEROTYPES AND REGIONAL DIVERSITY
E. coli strains are typically identified serologically by
two surface antigens; the somatic (O) and the flagellar (H),
of which there are ~186 and 53 types, respectively. The
serotype identity of STEC strains has been used widely to
identify STEC strains with the potential to cause severe
diseases, but serotype is not a virulence factor and E. coli
strains can carry any combination of O and H antigens; thus,
the number of E. coli serotypes is very large. An estimated
470 STEC serotypes have been reported (105) that can
produce any one of the 12 Stx1 and Stx2 subtypes or
combinations of these subtypes. However, not all Stx
subtypes appear to cause human illness, possibly because
these strains lack known adherence factors associated with
human illness. The estimated number of STEC serotypes
that causes human illness ranges from .60 (4) to .100
(77).
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Incidences of STEC strains causing foodborne infec-
tions have been reported from numerous countries world-
wide (77). Serotype O157:H7 is the prototypic STEC that
has caused infections worldwide. Serotype O26:H11 also
seems prevalent and has caused infections in many
countries, but other serotypes have caused infections only
in a particular country or region (5, 98, 120), suggesting that
there may be regional variations in STEC serotypes of
importance. For example, in 2009, the EFSA (37) identified
STEC with stx and eae from five O groups (O157, O26,
O103, O111, and O145), also known as the ‘‘big 5,’’ as
being of health concern in the European Union (EU).
Similarly, in the United States, six O types (O26, O45,
O103, O111, O121, and O145), or the ‘‘big 6,’’ have been
found to account for .75% of clinical non-O157 STEC
infections (25, 68). As a result, in 2011, the U.S. Department
of Agriculture Food Safety Inspection Service (156)
declared the ‘‘big 6’’ STEC O types that carry stx and eae
and the STEC O157 strains as adulterants in raw nonintact
beef and intact beef products intended for nonintact use.
Although many of these O types of importance identified by
various public health agencies are the same, types O121 and
O45, which are on the U.S. priority list, are not listed as
types of concern in other countries (77).
The evidence for geographic clustering and divergence
seems to apply to both different STEC serotypes and strains
within serotypes. Mellor et al. (101) used multilocus
genotyping to examine O157:H7 strains isolated in the
United States versus Australia and found that the strains
differed in both genotype and genetic markers and virulence
genes. Feng et al. (43) used multilocus sequence typing to
characterize O113:H21 strains that have caused HUS in
Australia versus environmental and clinical strains isolated
elsewhere in the world and found that even though all the
strains were within the same STEC clonal group, the
Australian O113:H21 strains were of sequence type 820,
which was not observed in the other strains.
STEC serotypes are evolving and moving among
countries, partly because of the ease of worldwide travel,
the vast international commerce of foods, and migration of
wildlife (106). For example, an atypical O157:H7 variant
that ferments sorbitol (SFO157) was first identified in
Bavaria, Germany, in 1988 (80) and has now been found in
other EU countries, including Finland (39), Austria, Czech
Republic (17), and Scotland (2). SFO157 strains seem to be
better able to adhere than do other O157 STEC (52, 132).
Perhaps related to this difference are reports that a higher
percentage of individuals with SFO157 infections develop
HUS than do individuals with other O157 STEC infections
(2, 132). Analysis of SFO157 strains isolated from various
EU countries revealed identical or near identical pulsed-field
gel electrophoresis (PFGE) profiles, suggesting that the same
strains may have spread between the countries (44). SFO157
strains have thus far not been isolated in the United States
but have been found in Australia (6), Egypt (134), and Korea
(90); however, some of the strains described in those reports
had genetic traits different from those of the German
SFO157 strain, including the presence of stx1. Most STEC
O26:H11 strains were initially found to produce only Stx1,
but isolates obtained later produced both Stx1 and Stx2.
Since the mid-1990s, a new clone of O26:H11 that produces
only Stx2 has emerged in Europe and has caused several
outbreaks of severe disease (1, 18, 31, 79, 92, 119, 141, 157,
163, 164). STEC O26 strains have also been isolated from
cases of HUS in Argentina (131), and O26 was the most
common non-O157 STEC serotype isolated from 1983 to
2002 (25) and 2000 to 2010 (62) in the United States.
Among the O26 human isolates in the United States from
1983 to 2002, 13% had stx2, of which only 2% had stx2
alone and the other 11% also had stx1 (25). Another example
of changing regional clustering is STEC O121, which was
not listed as being of concern in many countries (77), but
together with O26, O103, O111, O117, and O145, O121
was listed as the third most common among the top six non-
O157 STEC serogroups associated with serious illness in
Canada (29). A strain of serotype O121:H19 (stx2 positive)
was implicated in a 2017 Canadian outbreak suspected to
have been associated with contaminated flour (108). STEC
O104 became a concern in the United States (77) because of
an outbreak of BD in 1994 associated with milk contam-
inated with a strain of O104:H21 (30). However, the large
outbreak of O104:H4 infection in Germany and France in
2011 (48) quickly raised our awareness of the health risks of
this serotype and sent a cautionary message concerning the
difficulties of anticipating STEC serotypes that may emerge
to cause severe illness. The O104:H4 outbreak strain has not
been found in the United States except for one strain isolated
from a patient who had travelled to Germany during the
outbreak period, thus highlighting the risk of pathogen
spread via travel.
Identification of the serotype of STEC causing a
particular group of infections is important in epidemiology
for detection, investigating outbreak incidences, and track-
ing global emergence. However, E. coli serotyping is
complex because of the large number of O and H antigens
that exist, and not all E. coli isolates can be serotyped.
Studies of STEC and enterotoxigenic E. coli (ETEC) strains
isolated from fresh produce revealed that .50% of the
isolates could not be typed or yielded only partial serotypes
(45, 46). Because many STEC virulence genes are on mobile
genetic elements that can be lost or transferred, it is not
unusual to find STEC strains of the same serotype that carry
different virulence genes and pose different health risks. As
a result, although serotype data can be useful for identifying
STEC strains, these data should not be assessed indepen-
dently but rather evaluated along with the other attributes
when determining health risks.
Key Points on Serotypes and Diversity
1. At least 470 STEC serotypes can produce any one or
more of the 12 known Stx subtypes.
2. The number of STEC serotypes that cause human illness
differs depending on reports but is probably .100.
3. Serotype is not a virulence factor and does not
(necessarily) predict the virulence profile and health
risks associated with a particular STEC but is useful in
outbreak investigations and for prevalence surveillance.
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OTHER FACTORS THAT AFFECT VIRULENCE
CHARACTERIZATION
Horizontal gene transfer. Mobile genetic elements
such as plasmids, bacteriophages, transposons, PAIs, and
insertion sequence elements play a major role in the
evolution of E. coli (161). Plasmids are highly diverse and
may possess genes for antibiotic resistance, virulence,
regulation, and adhesins. Through the process of conjuga-
tion, plasmids can transfer small or large fragments of DNA
between bacteria and convey various traits to the recipient.
Some bacteriophages have the capacity to mobilize genes, as
indicated by the enormous proportion of fecal phage
particles that contain bacterial DNA. Through lysogenic
conversion of resident intestinal bacteria, phage may
introduce new phenotypic traits, such as antibiotic resistance
and the ability to produce exotoxins (23). Stx-converting
bacteriophage (Stx phage) carry the stx gene and can
lysogenize nonpathogenic bacterial strains and convert them
into STEC (69). Stx phage, therefore, represent highly
mobile genetic elements that play an important role in Stx
expression, in horizontal gene transfer, and in STEC genome
diversification. One example is the Stx-producing EAEC
O104:H4 strain, which caused a large outbreak in Germany
in 2011 (48). Some researchers have hypothesized that this
strain originated from a genetically primitive lineage of E.
coli in a confined geographical area but evolved via several
independent streams of horizontal gene exchange (11, 14,
130).
Evidence from Central Europe and Italy indicates that
O26:H11 strains have been shifting from carrying stx1 only
to carrying stx1 and stx2 and now to carrying stx2 only and
that those strains with only stx2 are more virulent than the
other O26 strains (1, 13, 18). As a further complication, loss
and gain of Stx-encoding phage has been observed in
O26:H11 strains (15). In the United States, mostly stx1-
bearing O26 strains have been found in foods, and isolation
of strains with stx2 alone has thus far not been common.
Frequent loss of stx genes in clinical STEC isolates has
been observed upon subcultivation (81), and stx-negative E.
coli O157:H7/H variants may occur at a low frequency in
patients with diarrhea or HUS (34, 138). The loss and gain
of Stx-encoding phage from E. coli in the human intestine or
during cultivation can result in strains with different
pathotypes. Such strains can present challenges for DNA
fingerprinting techniques (such as PFGE), resulting in
variable diagnostic results, and can have clinical, epidemi-
ological, and evolutionary implications.
Free and infectious stx phage can be found in high
densities in fecal samples from healthy humans, in
environments polluted with human and animal feces, and
in foods (73, 97, 109). As a result, molecular detection of stx
genes in a sample merely reflects the presence of stx genes
(phage), and results will have to be confirmed through
isolation and characterization of the STEC strain. Other
enterobacterial species also known to acquire stx phage are
Shigella dysenteriae type 1, Shigella flexneri, Shigella
sonnei, Citrobacter freundii, E. albertii, Acinetobacter
haemolyticus, Aeromonas caviae, and E. cloacae (3, 10,
21, 28, 64, 69, 84, 117), and these genes may also be
detected by stx-specific assays. Usually, detection of one or
more stx genes in foods associated with an outbreak coupled
with supporting epidemiological data provide sufficient
information to link the food to human illness. However,
free stx phage found in foods may result in false-positive
findings. Alternative methods that can eliminate or signif-
icantly reduce the detection of free stx phage may allow
more specific detection of STEC in foods (129).
More than 170 PAIs carrying important virulence
properties have been annotated as genomic islands in the
sequences of the STEC O157:H7 strains EDL933 and Sakai
(67, 123). One of these PAIs carries the LEE, which has the
eae gene necessary for the attaching and effacing lesion.
Another PAI, designated O island 122 (OI-122), carries the
large virulence gene cluster efa1-lifA (85, 113, 145) and has
frequently been found in STEC strains associated with
severe human disease (82, 87, 107). OI-122 has multiple
other functions and appears to be involved in cell adhesion,
immunosuppression, disruption of epithelial barrier func-
tion, and intestinal colonization (86).
Another important PAI is OI-57, which harbors adfO, a
putative virulence gene for adhesion, and ckf, which encodes
a putative killing factor for bacterial cells. OI-57 is present in
the majority of the STEC genomes and in a proportion of
human EPEC, suggesting that this PAI could be involved in
the attaching and effacing colonization of the intestinal
mucosa (74).
A more complete description of many of the additional
mobile genetic elements is beyond the scope of this
assessment, but a few examples of recombinant strains
derived from these elements, also referred to as hybrid
strains, deserve mention here.
EAEC-STEC. E. coli O104:H4 from the German
outbreak in 2011 has stx2a and EAEC pAA (the virulence
plasmid with genes coding for AAF/I, AggR, and SepA),
extended-spectrum b-lactamase antibiotic resistance plas-
mid, and chromosomal genes for Aat (dispersin trans-
locator), SigA (IgA protease-like homolog), and Pic (serine
protease precursor) (19, 20).
EPEC-STEC. E. coli serotypes O26:H11, O55:H9, and
O80:H2 from HUS patients in Austria and Italy have stx2f,
the EPEC-associated efa1 gene that resides on PAI OI-122,
the STEC plasmid genes ehxA, espP, and katP, and intimin
types n or b (63).
ExPEC-STEC. E. coli O80:H2 strains reported from
France and Spain have stx2a, stx2c, or stx2d, intimin gene eae-
n, and at least four genes characteristic of pS88 (sitA, cia,
hlyF, and ompT) and other genes associated with ExPEC
virulence (iss, iroN, and cvaA) (142). Thirteen O2:H6 strains
with sequence type 141 had stx2b, saa, and ExPEC-
associated genes vat, clb island, cdiAB, and ybt clusters;
12 also had iro, 10 had a-hly, cnf1, the pap cluster, and hek,
and 9 also had the sfaII cluster (16).
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ETEC-STEC. An E. coli O2:H27 strain with stx2a,
ehxA, and estIa (gene for ETEC heat-stable toxin) was
isolated from two people (one had diarrhea and one was
asymptomatic), and an O101:NM strain with stx2a, ehxA,
estIa, and eae was isolated from a patient with HUS in
Finland (114). E. coli O159:HUT sequence type 171, with
stx2a, elt (gene for ETEC heat-labile toxin), and ETEC
colonization factor CS12, was isolated from a patient with
diarrhea in Korea (116). Four O15:H16, five O175:H28, two
O136:HNM, and one ONT:H16 human clinical isolate from
Germany were positive for stx2g and estIa (the O15:H16
strains were also positive for the plasmid-encoded astA and
espP) (125).
A less well-characterized stx2f-positive O8:H19 isolate
from a patient with HUS in The Netherlands was also
positive for the eae gene but negative for ehxA (54). STEC
O8:H19 strains do not usually have stx2f.
In summary, mobile DNA and horizontal gene transfer
in E. coli can transfer virulence genes to other bacteria and
pose an ongoing challenge in diagnostic procedures and
detection methodology and in making health risk determi-
nations for STEC found in foods.
Key Points on Horizontal Gene Transfer
1. Independent streams of horizontal gene exchange play a
major role in STEC diversity.
2. Mobile DNA and horizontal gene transfer in E. coli poses
an ongoing challenge for diagnostic and detection
methods and for the risk assessment of STEC found in
foods.
3. Other diarrheagenic E. coli pathotypes are also known to
acquire stx phage.
4. Other species of Enterobacteriaceae are also known to
acquire stx phage.
Dose-response assessment for STEC virulence
types. Stx is the main STEC virulence factor, but it is
seldom produced in foods unless the food has undergone
severe time and temperature abuse. Significant production of
Stx1 can occur in milk and ground beef when these have
been subjected to vigorous aeration at 378C for 48 h (159).
However, these conditions are seldom encountered in
normal food production processes because they result in
spoilage, which will render the food unfit for consumption.
Foodborne STEC infections typically occur from ingesting
STEC-contaminated food and other vehicles. The STEC
cells then bind to intestinal epithelial cells and express Stx.
The severity of disease outcomes in STEC infections may
also depend on the number of STEC cells ingested. The
infectious doses of STEC are suspected to be low but can
differ depending on serotype and strain. Disease outcomes
also can differ depending on the individual’s susceptibility.
Limited information is available on the dose-response
of STEC. The risk of life threatening illness in humans and
the absence of an animal model that replicates human
pathology preclude experimental determination of the STEC
dose-response. Estimates of dose-response have been made
for STEC O157:H7 based levels of the pathogen in food and
consumption data from patients in outbreaks. Exposure to
,100 cells of STEC O157:H7 may be sufficient to cause
infection. Exposure estimates have been reported from three
outbreaks in which the level of STEC O157:H7 in the food
at consumption could be determined: 2 to 45 cells in salami
(152), ,700 cells in beef patties (155), and 31 to 35 cells in
pumpkin salad with seafood sauce (150). These estimates
are supported by reports of STEC O157:H7 levels
(expressed either as CFU or most probable number
[MPN]) in a variety of foods involved in outbreaks: raw
milk cheeses, 5 to 10 CFU/g (147) and 0.0037 to 0.0095
MPN/g (60), and beef patties, 1.45 MPN/g (65) and 0.022
MPN/g (59). The probability of infection after exposure to a
single viable STEC O157 cell is significant. In one
foodborne outbreak, the median probability was estimated
as 25% for children and 17% for adults (150). The frequency
of transmission in childcare centers and among family
members also suggests that the probability of infection per
cell is significant.
It is not known whether the dose-response of STEC
strains that use intimin for attachment differs among
serogroups, although because of the known genetic and
physiological variability of STEC the differences can be
presumed to be significant. However, it is not currently
possible to identify STEC strains that have a higher
probability of causing infection than does STEC O157:H7.
An investigation of an STEC infection outbreak involving
serotypes O145:H28 and O26:H11 in ice cream revealed
levels of 2.4 MPN/g for O145 and 0.03 MPN/g for O26
(27). In an outbreak of STEC O111:H infection associated
with fermented sausage, the estimated exposure dose was 1
cell per 10 g (120). Thus, the probability of infection upon
exposure to other STEC strains may approach that of
O157:H7.
In addition to STEC strain factors, host factors very
likely also affect dose-response relationships and disease
outcomes. Individuals with weakened immune systems,
such as frail or elderly persons, and individuals that lack
acquired immunity, such as young children, have the highest
rate of illness and HUS (66). In one study in Germany,
examination of the relation between major STEC O groups
and the affected individual’s age and severity of illness
revealed that age was a relevant factor in the severity of
STEC illness (127). In another study in Germany, in
children younger than 3 years of age, the relevant risk
factors were contact with ruminants and consumption of raw
milk; foods such as meats and sausages were not STEC risk
factors until the children were at least 10 years old (160).
These factors should be considered when extrapolating dose-
response estimates to different demographic groups or
epidemiological scenarios. Heterogeneity in exposure as
influenced by infectivity, dose, attack rates, host suscepti-
bility, food, etc. also needs to be taken into account when
determining dose-responses in O157:H7 outbreaks (149).
Key Points on Dose-Response
1. The severity of disease outcome from infections may
depend on the number of STEC cells ingested.
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2. The infectious dose of STEC is suspected to be low but
can differ among serotypes and among strains.
3. Disease outcome severity differs depending on an
individual’s susceptibility.
Human and other factors. Although selected STEC
traits may be used to assess potential health risks, they
provide no conclusive prediction on the outcome or the
severity of disease. STEC pathogenesis is highly complex,
and aside from STEC virulence traits other factors may also
play a role in disease outcome. For example, coculturing
O157:H7 strains with commensal E. coli can increase Stx2
production and the virulence of O157:H7 strains in mice,
suggesting that there is a synergistic effect of STEC and the
typical intestinal bacteria (61). Some clades of O157:H7
overexpress Stx2 and are more often associated with severe
human infections (111). Severity of STEC infection
outcomes can also be affected by synergistic effects with
other organisms. In a 2001 to 2010 survey of 1,800 non-
O157 STEC infections, 3.6% of the cases had multiple
etiologies (93). In some cases, patients were coinfected with
a non-O157 STEC and O157:H7, Cryptosporidium, or
Campylobacter. Coinfections with pathogenic E. coli and
other pathogens have been characterized by severe diarrhea
(153).
The occurrence and severity of STEC infections are also
affected by human factors and genetics, which can affect
STEC colonization and thus the severity of STEC infection
outcomes (133). The impact of human individual suscepti-
bility is also indicated by reports of asymptomatic STEC
carriers (144). In a study of fecal samples from 5,590
asymptomatic workers from the Swiss meat processing
industry, 3.5% of the samples were positive for stx genes, 47
STEC strains were isolated, and some strains also had the
eae gene, including one isolate of the O157:H7 serotype
(143). In a study in northern Italy of fecal samples from 350
asymptomatic farm workers from 276 dairy farms and 50
abattoir workers from seven facilities, 1.1% of the farm
workers were infected with O157:H7 strains that had eae
plus stx1, stx2, or both (140). All of these individuals were
adults, and although they were asymptomatic, they could
have posed health risks to younger individuals. An
asymptomatic mother with an eae-negative O146:H28 strain
with stx2b, a Stx subtype usually associated with asymp-
tomatic carriage (143), transmitted the strain to her child,
resulting in a neonatal case of HUS (148).
Other evidence on the effects of human factors include a
case in Finland, where an eae-negative, stx1c-positive
O78:H strain was isolated from the fecal samples of all
five family members (91). The Stx1c subtype is most
prevalent in STEC strains from sheep (24), and infections by
Stx1c-producing strains tends to be mild or asymptomatic
(51). Accordingly, the parents and the older siblings had no
symptoms, but the 2-year-old child developed HUS. In
another study, 3-year-old identical twins were infected with
the same O157:H7 strain but had different outcomes; one
twin developed HUS but the other did not (75). The authors
speculated that differences in inoculum size may have
impacted the disease outcomes. These examples suggest that
human genetics and individual susceptibility can greatly
contribute to disease outcomes. Hence, no STEC strain may
be ‘‘without risk’’; all STEC strains probably pose some
health risk to some individuals but maybe not to everyone.
Thus, instead of the commonly used terms such as
pathogenic and nonpathogenic, perhaps STEC strains should
more appropriately be designated as having a low or high
health risk. Such terminologies have been proposed and
advocated by others for distinguishing the health risk
associated with STEC strains (88, 136).
Medical histories can reveal that a particular STEC
serotype has caused severe infections and outbreaks;
therefore, serotype information may be useful when
characterizing the STEC health risks, but such data need
to be interpreted with caution. STEC strains of serotype
O8:H19 have been found in flour in the United States and
are common in cattle (76), and an O8:H19 strain also was
reported to have caused HUS in a boy in The Netherlands
(54). Most O8:H19 strains do not have eae and can have
stx1a, stx2a, or both genes, but the HUS-causing strain from
The Netherlands was unusual in that it had eae and stx2f.
Most of the STEC virulence genes reside on mobile genetic
elements that can be transferred between strains and, as
evident from various studies, strains with the same serotype
can have different virulence genes and therefore can differ in
their potential to cause severe illnesses. The case in The
Netherlands also shows that under certain circumstances
stx2f can cause severe disease, supporting the conclusion that
all STEC strains can pose health risks to certain individuals.
The fact that strains of the same serotype can differ in
pathotype greatly complicates health risk decision making
and indicates the difficulty in establishing uniform criteria
that can be used to determine whether an STEC has the
potential to cause severe disease. Future research may
identify better traits that can be used in STEC health risk
characterization, in which case the critical health risk criteria
currently used will need to be modified accordingly.
Key Points on Human and Other Factors
1. Human factors are thought to play a role in the outcome
and severity of STEC diseases, but this role is
undetermined.
2. All STEC strains have the potential to cause diarrhea and
pose some health risks, but those that carry certain
virulence traits are regarded as high risk and can cause
HUS.
CONCLUSIONS
1. Adherence factors are critical for STEC pathogenicity.
2. The principal adherence factor in STEC is the intimin
protein coded by the eae gene.
3. The AAF adhesins regulated by the aggR gene of EAEC
are also an effective means for adherence.
4. Other putative adherence factor genes are saa, sab, paa,
efa1, ompA, lpfA, toxB, and the LAA PAI.
5. Twelve subtypes of Stx have been identified: Stx1a,
Stx1c, Stx1d, Stx1e, Stx2a to Stx2g, and Stx2i, encoded
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by genes stx1a, stx1c, stx1d, stx1e, stx2a to stx2g, and stx2i,
respectively.
6. The gene stx2a is most often present in LEE (eae)–
positive STEC and has consistently been associated
with HUS.
7. The gene stx2a has also been found in eae-negative,
aggR-positive STEC that have caused HUS.
8. The gene stx2d in LEE-negative STEC has, to a lesser
degree, been reported from HUS cases, but not all
STEC strains with stx2d cause severe disease.
9. HUS cases in which other Stx subtypes were identified
indicate that other factors such as host susceptibility and
the genetic cocktail of virulence genes in an individual
isolate may affect the association of these other Stx
subtypes with severe diseases.
10. An estimated 470 STEC serotypes can produce any one
or more of the 12 known Stx subtypes.
11. The number of STEC serotypes that cause human illness
differs depending on the individual report and is
probably .100.
12. Serotype is not a virulence factor and does not
(necessarily) predict risk or virulence profile of an
STEC strain but is useful in outbreak investigations and
for prevalence and surveillance studies.
13. Independent horizontal gene exchanges play a major
role in STEC pathogenicity and diversity.
14. Mobile DNA and horizontal gene transfer in E. coli
transfers virulence genes to other bacteria and poses an
ongoing challenge to diagnostic procedures and detec-
tion methodologies and to the risk assessment of STEC
findings.
15. Other diarrheagenic E. coli pathotypes are known to
acquire stx phage.
16. Other species of Enterobacteriaceae are also known to
acquire stx phage.
17. The severity of disease outcome in infections may
depend on the number of STEC cells ingested.
18. The infectious dose of STEC is suspected to be low but
can differ between serotypes and strains.
19. Disease outcomes differ depending on individual
susceptibility.
20. Human factors are thought to play a role in STEC
diseases, but this role is undetermined.
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